Stock WELCURE6 WELCURE DRUGS & PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Welcure Drugs & Pharmaceuticals Limited

Equities

WELCURE6

INE331C01017

Market Closed - Bombay S.E.
Other stock markets
 12:30:42 18/05/2024 pm IST 		5-day change 1st Jan Change
5.4 INR 0.00% Intraday chart for Welcure Drugs & Pharmaceuticals Limited +12.50% +40.26%
22/03 Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024 CI
16/02 Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mitashi Bisaria as Company Secretary / Compliance Officer, Effective October 8, 2022
Welcure Drugs & Pharmaceuticals Limited Announces Director Resignations, with Effect from October 8, 2022
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Sudhir Chandra as Managing Director, with Effect from October 8, 2022
Welcure Drugs & Pharmaceuticals Limited Announces Appointment of Directors
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Director
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Welcure Drugs and Pharmaceuticals' Net Profit Jumps in Fiscal Q4
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. WELCURE6 Stock
  4. News Welcure Drugs & Pharmaceuticals Limited
  5. Other languages
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW